Replimune Group's shares soared after an FDA advisory panel endorsed its RP1 drug trial results for skin cancer, prompting Wedbush Securities to upgrade the stock to outperform. Jersey Mike's shares rose 1% on its public debut, opening at $21, below its $23 offering price, and closing down 6% on the first day.
Chevron's shares increased slightly after reporting a net income of $12.1 billion, nearly 400% higher than last year, while ExxonMobil's shares fell 2% due to weaker-than-expected earnings of $3.52 per share, missing the $3.60 estimate. Moderna's shares dropped over 4% despite beating earnings expectations, reporting a loss of $1.97 per share on $145 million in revenue.
Amazon's shares surged more than 11% after reporting better-than-expected revenue and a 37% year-over-year growth in its cloud segment, exceeding Wall Street's 31% growth forecast. Conversely, Apple saw a 7% decline in its shares despite strong fiscal third-quarter revenue driven by a 22% increase in iPhone sales.
Coinbase's shares fell over 5% after reporting a $359.5 million loss, significantly worse than the anticipated loss of 17 cents per share. Reddit's shares dropped 12% amid concerns over search-referral traffic, despite beating earnings expectations.
Lastly, Novo Nordisk's shares fell more than 10% after its ziltivekimab drug trial failed to show significant cardiovascular benefits compared to placebo